A new Phase I clinical trial from London Health Sciences Centre Research Institute (LHSCRI) has found high-precision ...

Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen.

Radiotherapy, or radiation therapy, is the clinical use of high energy rays (ionizing radiation) to induce DNA damage in all exposed cells to ultimately kill cancer cells or prevent cancer growth.

Lymphoma is a type of cancer that begins in immune system cells, called lymphocytes. It generally presents as a solid tumor of lymphoid cells and can develop in the lymph nodes, spleen, bone ...

A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[18 F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary Aldosteronism ...